Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people ...

A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...

Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease ...

In a nutshell People with type 2 diabetes taking semaglutide (Ozempic/Wegovy) showed up to 46% lower dementia risk compared ...

The study, carried out by experts from the University of Nottingham and funded by the National Institute for Health Research ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...

Although there’s no proper cure for dementia, prevention is possible even from a young age. It’s the spotting of early signs of the disease that helps in preventing the disease with an early ...

New research suggests that dementia prevention should begin much earlier than previously thought—possibly as early as ...

While there's no cure for dementia, sometimes, cognitive decline can be slowed, especially when caught early. Here, neurologists reveal the silent dementia sign that's often overlooked.

Over a hundred new drugs which could halt dementia are being developed at the “start of a journey to a cure”, scientists say. Experts have heralded the findings from a global review of drugs ...